Skip to main content

Table 2 Results of PlGF and fetal flow tests, by outcome and diagnosis (N=89)

From: Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study

  Normal PlGF Low PlGF Very Low PlGF
Fetal flow Normal Abnormal Normal Abnormal Normal Abnormal
n 22 0 23 3 24 17
Percent of N (24.7) 0.0 (25.8) (3.4) (27.0) (19.1)
Preterm 5 (22.7)   14 (60.9) 3 (100.0) 22 (91.7) 17 (100.0)
IUGR 0 (0.0)   3 (13.0) 3 (100.0) 9 (37.5) 7 (41.2)
CHT 8 (36.4)   11 (47.8) 0 (0.0) 2 (8.3) 3 (17.6)
GHT 10 (45.5)   3 (13.0) 1 (33.3) 2 (8.3) 1 (5.9)
HELLP 0 (0.0)   2 (8.7) 0 (0.0) 6 (25.0) 4 (23.5)
PE 1 (4.5)   2 (8.7) 1 (33.3) 10 (41.7) 5 (29.4)
SIPE 3 (13.6)   5 (21.7) 1 (33.3) 4 (16.7) 4 (23.5)
  1. Breakout of N=89 subjects by three placental growth factor test result groups (normal PlGF≥100, low 12<PlGF<100, and very low PlGF≤12) and two fetal flow groups (abnormal, normal). The breakout by outcomes (preterm birth, IUGR infant) and diagnosis shows the number and percent (relative to n) for each category. Intrauterine growth restriction (IUGR); chronic hypertension (CHT); gestational hypertension (GHT); hemolysis, elevated liver enzymes and low platelet count syndrome (HELLP); preeclampsia (PE); superimposed preeclampsia (SIPE).